APA

Hantschel O., Rix U., Schmidt U., Bürckstümmer T., Kneidinger M., Schütze G., Colinge J., Bennett K. L., Ellmeier W., Valent P. & Superti-Furga G. (20071024). The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Hantschel Oliver, Rix Uwe, Schmidt Uwe, Bürckstümmer Tilmann, Kneidinger Michael, Schütze Gregor, Colinge Jacques, Bennett Keiryn L, Ellmeier Wilfried, Valent Peter and Superti-Furga Giulio. 20071024. The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Hantschel O., Rix U., Schmidt U., Bürckstümmer T., Kneidinger M., Schütze G., Colinge J., Bennett K. L., Ellmeier W., Valent P. and Superti-Furga G. (20071024). The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Hantschel Oliver, Rix Uwe, Schmidt Uwe, Bürckstümmer Tilmann, Kneidinger Michael, Schütze Gregor, Colinge Jacques, Bennett Keiryn L, Ellmeier Wilfried, Valent Peter and Superti-Furga Giulio. The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. : Proceedings of the National Academy of Sciences of the United States of America. 20071024.